Company Overview

Stemsation International, Inc. (OTC: STSN) is a micro-cap wellness and nutraceutical company focused on the development, marketing, and distribution of dietary supplements and health products. Public disclosures and OTC market materials indicate that the company has positioned itself around products associated with stem-cell nutrition, wellness support, and natural health formulations. The company operates within the broader health supplements, direct-selling, and consumer wellness industries, with revenue historically tied to product sales through distributor networks and affiliated marketing programs.

The company’s business model has evolved through multiple corporate restructurings and strategic repositioning efforts common among OTC-listed issuers. Available public records indicate that STSN pursued growth through brand development, distribution relationships, and expansion into wellness-oriented consumer markets. However, detailed operational disclosures have been limited in recent years, and some aspects of the company’s historical operating scale and financial activity remain difficult to independently confirm through current public filings. Data inconclusive based on available public sources.

Business Operations

Public filings and OTC disclosures indicate that STSN’s operations have centered on the commercialization of wellness products under its supplement and health-product portfolio. The company historically generated revenue through product distribution, affiliate marketing arrangements, and direct consumer sales channels. Its operating activities appear to have been concentrated primarily in the United States, with references to broader international marketing ambitions through distributor-based networks.

The company’s controlled assets primarily consisted of intellectual property related to formulations, branding, marketing systems, and distribution relationships rather than large-scale manufacturing infrastructure. Publicly available information does not clearly identify major active subsidiaries, manufacturing facilities, or material joint ventures currently contributing significant operating revenue. Data inconclusive based on available public sources regarding the present scale of active operations, international revenue contribution, and strategic commercial partnerships.

Strategic Position & Investments

STSN’s strategic positioning has historically focused on participation in the growing global wellness and nutraceutical sector, particularly products marketed around stem-cell support and nutritional optimization. Company communications and investor materials have emphasized consumer demand for preventative health products, wellness supplementation, and alternative health solutions as key growth themes. The company also explored distributor-driven expansion strategies intended to increase product reach without building extensive retail infrastructure.

Available public disclosures do not show evidence of major recent acquisitions, large institutional investments, or significant ownership stakes in operating portfolio companies comparable to larger publicly traded health-product firms. While the company has referenced innovation and wellness-oriented product development, publicly verifiable information regarding proprietary technologies, research partnerships, or material investment in emerging biotechnology sectors remains limited. Data inconclusive based on available public sources concerning recent capital deployment, acquisition activity, and long-term strategic investment programs.

Geographic Footprint

STSN has historically been headquartered in the United States, with operational activity primarily tied to the domestic consumer wellness market. Company materials have periodically referenced international distributor opportunities and global expansion objectives, though independently verifiable evidence of substantial overseas operating infrastructure remains limited.

Public information does not indicate a large physical international footprint, multinational manufacturing network, or significant regional operating divisions across Europe, Asia-Pacific, or Latin America. The company’s market presence appears to have been primarily associated with OTC market participation and limited-scale wellness product distribution. Data inconclusive based on available public sources regarding current international operational scale and geographic revenue segmentation.

Leadership & Governance

Publicly available governance information for STSN has varied over time due to changes in management, reporting status, and corporate activity. Historical filings and OTC disclosures identify leadership personnel associated with executive management, finance, and corporate administration functions, although current executive data may not be consistently updated across all public databases. The company’s strategic messaging has generally emphasized entrepreneurial growth, wellness-market participation, and shareholder value creation through product commercialization and distribution expansion.

Key executives identified in public records include:

• John W. Meyer – Chief Executive Officer
• Donald “DJ” Matheson – Executive leadership roles referenced in historical company materials
• Corporate officer and director information – Data inconclusive based on available public sources

Governance transparency appears more limited than that of fully reporting exchange-listed corporations, and investors typically rely on OTC Markets disclosures, historical company releases, and available regulatory filings for management and operational updates.